Morpheus 8 Whereas Evolve and Evoke are completely noninvasive, allowing you to multitask throughout the painless hands-free sessions, Morpheus8 is a powerful, minimally invasive treatment that combines the benefits of radiofrequency with microneedling
For real-time patent expiry tracking, DrugPatentWatch provides the consolidated view needed to model this timeline accurately
Future Outlook Over the next five years, the India GLP-1 Receptor Agonist Market is projected to undergo significant growth fueled by the continuous rise in diabetes cases, enhanced awareness about chronic disease management, and ongoing innovations in drug formulations
Type 2 diabetes mellitus and cardiometabolic outcomes in metabolic dysfunction-associated steatotic liver disease population
Selected Research References Pickart L, Margolina A
Novo Nordisk reports up to 13.8% weight loss in people with obesity receiving semaglutide in phase 2 trial